Beck Mack & Oliver »

Ligand Pharmaceuticals In shares owned by Beck Mack & Oliver

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Beck Mack & Oliver from 13F filings

Historical chart of Beck Mack & Oliver investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Beck Mack & Oliver consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Beck Mack & Oliver

Quarter filed Position value Share count Share price at filing
2026-03-31 $338k 1.7k 199.65

More positions owned by Beck Mack & Oliver

Apollo Global Mgmt (APO)
Alphabet Inc Class C cs (GOOG)
Blackstone Group Inc Com Cl A (BX)
Arthur J. Gallagher & Co. (AJG)
Sunbelt Rentals Holdings (SUNB)
Microsoft Corporation (MSFT)
Ferguson (FERG)
Charles Schwab Corporation (SCHW)
Tempur-Pedic International (SGI)
RadNet (RDNT)
Labcorp Holdings (LH)
Zurn Water Solutions Corp Zws (ZWS)
Credit Acceptance (CACC)
Waters Corporation (WAT)
American Express Company (AXP)

View all positions for Beck Mack & Oliver

Top funds holding Ligand Pharmaceuticals In

BlackRock
Vanguard Group
Vanguard Portfolio Management
Henderson Group
Vanguard Capital Management
Invesco
State Street Corporation
FMR
Nomura Asset Management International
Franklin Resources
Chicago Capital
Geode Capital Management
Massachusetts Financial Services
Congress Asset Management
Stephens Investment Management Group

View all funds holding Ligand Pharmaceuticals In